Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Lueftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL), or endocrine monotherapy (ET), or chemotherapy (CT) as first-line (1L) treatment (tx) in patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Results of fourth interim analysis (IA) from RIBANNA.JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Luftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) locally advanced or metastatic breast cancer: Fourth interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 82. H. 4. 2022
Schwab, Roxana; Droste, Annika; Stewen, Kathrin et al.
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 PandemicINTERNATIONAL JOURNAL OF GENERAL MEDICINE. Bd. 15. 2022 S. 7039-7052
Woelber, Linn; Hampl, Monika; Eulenburg, Christine Zu et al.
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva StudyCANCERS. Bd. 14. H. 2. 2022
Lecuru, F.; Sehouli, J.; Vergote, I. B. et al.
Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trialANNALS OF ONCOLOGY. Bd. 33. H. 7. 2022 S. S809-S809
Heitz, F.; Sehouli, J.; Fotopoulou, C. et al.
Role of cytoreductive Surgery in Patients who did not undergo Surgery for first Recurrence: A Sub-analysis of the DESKTOP III StudyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E86-E87
Feiten, Stefan; Scholl, Isabelle; Duennebacke, Jan et al.
Shared decision-making in routine breast cancer care in Germany-A cross-sectional studyPSYCHO-ONCOLOGY. Bd. 31. H. 7. 2022 S. 1120-1126
Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf et al.
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference-Substudy of the randomised phase III GAIN-2 studyBREAST. Bd. 66. 2022 S. 110-117
Krajnak, S.; Trier, J. P.; Anic, K. et al.
Synergistic anticancer Effects of low-dose Vinorelbine in Combination with Alpelisib in Hormone Receptor-positive PIK3CA mutant Breast Carcinoma CellsGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E110-E110
Kiweler, Nicole; Schwarz, Helena; Nguyen, Alexandra et al.
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracilCELL BIOLOGY AND TOXICOLOGY. 2022